What is Nplate (romiplostim) from Amgen USA used for?
Nplate (romiplostim) is an Amgen medicine approved for treating certain types of low platelet counts (thrombocytopenia) by helping stimulate platelet production. It is used in adults with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to other treatments, and in some children based on labeling. [1][2]
How does Nplate work?
Nplate is a thrombopoietin receptor agonist. It binds to the thrombopoietin receptor on cells involved in platelet production, which increases the production of platelets and helps raise low platelet counts. [1]
How is Nplate given in the US?
Nplate is given by injection (subcutaneous). Dosing is adjusted based on platelet response to help keep platelet counts in a safe target range. [1][2]
Common safety concerns patients ask about
Because Nplate increases platelet counts, the main safety consideration is avoiding excessively high platelets. Your clinician monitors platelet levels and adjusts dosing accordingly. Other risks discussed in standard prescribing information include complications related to clotting/thrombosis risk and other adverse reactions reported for romiplostim. [1][2]
What does Amgen USA’s Nplate prescribing information say about dose adjustments?
The prescribing information includes platelet-guided dose adjustments. The goal is to use the lowest dose that achieves and maintains an acceptable platelet count for ITP management, with specific instructions to reduce or hold doses if platelets rise too high. [1][2]
Is Nplate the only romiplostim brand?
Nplate is the brand name used for romiplostim. If you are seeing different names or formulations, it usually reflects how the drug is packaged or referenced, but romiplostim is the active ingredient. (Coverage and substitutions depend on the specific product available and payer rules.) [1]
Where to find Amgen USA details (label, full prescribing info)
You can reference the official US prescribing information and related documents for Nplate through Amgen’s US product resources, or the US FDA labeling database. [1][2]
Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/
[2] https://www.amgen.com/our-medicines/